Tracker Certificate

    Vontobel Gene Therapy Performance Index

    Open-End  |  Currency: EUR

    EUR
    Bid volume

    EUR
    Ask volume

    Spread

    Vontobel Gene Therapy Performance Index: 104.5351 USD|Last Update:

    Product Overview

    Underlying
    Key figures
    Ratio
    		1.1663
    Return (since Inception)
    		6.85%
    Volatility p.a.
    		27.20%
    Maximum Drawdown
    		-31.10%
    Number of Positions
    		16
    Sharpe Ratio
    		0.03

    Index Overview

    Index Allocation

    Share    		100.00%

    Index Composition

    InstrumentCountriesSectorsCurrenciesWeight

    Neurocrine Biosciences Inc.

    ISIN US64125C1099

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 7.42%

    BioNTech SE

    ISIN US09075V1026

    		Countries: GermanySectors: Health Care Currencies: USDWeight: 7.25%

    PTC Therapeutics Inc

    ISIN US69366J2006

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 7.18%

    Novo Nordisk A/S

    ISIN DK0062498333

    		Countries: DenmarkSectors: Health Care Currencies: DKKWeight: 6.70%

    Lonza Group AG

    ISIN CH0013841017

    		Countries: SwitzerlandSectors: Health Care Currencies: CHFWeight: 6.59%

    Roche Holding AG

    ISIN CH0012032048

    		Countries: SwitzerlandSectors: Health Care Currencies: CHFWeight: 6.48%

    CSL Ltd

    ISIN AU000000CSL8

    		Countries: AustraliaSectors: Health Care Currencies: AUDWeight: 6.45%

    Moderna Inc.

    ISIN US60770K1079

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 6.43%

    Novartis AG

    ISIN CH0012005267

    		Countries: SwitzerlandSectors: Health Care Currencies: CHFWeight: 6.38%

    Amicus Therapeutics Inc.

    ISIN US03152W1099

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 6.32%

    Regeneron Pharmaceuticals Inc.

    ISIN US75886F1075

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 6.10%

    Daiichi Sankyo Co. Ltd.

    ISIN JP3475350009

    		Countries: JapanSectors: Health Care Currencies: JPYWeight: 6.07%

    Krystal Biotech Inc.

    ISIN US5011471027

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 5.87%

    CRISPR Therapeutics AG

    ISIN CH0334081137

    		Countries: SwitzerlandSectors: Health Care Currencies: USDWeight: 5.48%

    Autolus Therapeutics PLC

    ISIN US05280R1005

    		Countries: United KingdomSectors: Health Care Currencies: USDWeight: 4.68%

    Allogene Therapeutics Inc.

    ISIN US0197701065

    		Countries: United StatesSectors: Health Care Currencies: USDWeight: 4.61%
    Subtotal Share:
    100.00%
    Total :
    100.00%

    Life Cycle

    Initial Fixing‌First trading day‌‌Open-End‌

    Product Information

    About this product

    Tracker certificates enable investors to invest in themes, strategies, regions, or countries, making it easier to diversify even with small amounts of money. Tracker certificates replicate the performance of the underlying asset without leverage, a cap, or capital protection. Investors participate nearly 1:1 in rising and falling prices of the underlying asset. The underlying assets can especially be indices or equity baskets. In this way, you can invest in a whole stock market or basket in only one transaction without having to buy all the individual stocks. This is why tracker certificates are a great product for targeted investment in specific themes.

    Learn more about Tracker Certificates

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    newletter overlay image

    Stay updated

    Subscribe to receive information about structured products

    Your personal data will be processed to provide information as per Vontobel Privacy Policy.

    Vontobel Markets – Bank Vontobel AG and/or affiliates. All rights reserved.

    Please read this information before continuing, as products and services contained on this website are not accessible to certain persons. The information and/or documents offered on this website represent marketing material pursuant to Art. 68 of the Swiss FinSA and are provided for information purposes only. On request, further documents such as the key information document or the prospectus/issue documentation are available free of charge whenever you wish.